INTELLIGENT BIO SOLUTIONS INC. Proceeds from Sale of Productive Assets
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Proceeds from Sale of Productive Assets of $40.16 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. proceeds from sale of productive assets for the quarter ending 2026-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from sale of productive assets for the quarter ending 2026-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from sale of productive assets for the quarter ending 2025-12-31 was $40.16K.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from sale of productive assets for the quarter ending 2025-09-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from sale of productive assets for fiscal 2026 was $40.16K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $0.00 derived: sum of 2 quarters · filed 2026-08-19 | $40.16K derived: sum of 3 quarters · filed 2026-08-19 | $40.16K 10-K · filed 2026-08-19 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $40.16K derived: sum of 2 quarters · filed 2026-08-19 | $40.16K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $40.16K 10-K · filed 2026-08-19 | $40.16K 10-Q · filed 2026-02-12 | ||
| 2025-09-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2026-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |